Das Klinikum Bayreuth ist das größte Krankenhaus der Stadt Bayreuth und akademisches Lehrkrankenhaus der Universität Erlangen-Nürnberg.

During the past decade, Klinikum Bayreuth conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Bayreuth" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored, "Anavex Life Sciences Corp." with 2 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials sponsored and "Technische Universität Dresden" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Bayreuth" #1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "ClinAssess GmbH" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator and "German Research Foundation" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Bayreuth" are "Lymphoma" (5 trials), "Breast Cancer" (4 trials), "Leukemia" (3 trials), "Metastatic Colorectal Cancer" (3 trials) and "Neuroblastoma" (3 trials). Many other conditions were trialed in "Klinikum Bayreuth" in a lesser frequency.

Most popular intervention types in "Klinikum Bayreuth" are "Drug" (33 trials), "Radiation" (12 trials), "Biological" (11 trials), "Procedure" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (11 trials), "radiation therapy" (11 trials), "doxorubicin hydrochloride" (9 trials), "vincristine sulfate" (9 trials) and "filgrastim" (7 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Bayreuth" are 40 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Bayreuth". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Klinikum Bayreuth, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Bayreuth, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Klinikum Bayreuth has several departments that took part in Clinical trials: "Klinikum Bayreuth, Medizinische Klinik IV" - 2 trials, "Department of Neurology, Klinikum Hohe Warte" - 2 trials